Submission of Audited Consolidated and Standalone Financial Results for the half-year and year ended 31st March, 2025 pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited financial results (standalone and consolidated) for FY25 along with an unmodified (clean) auditor's opinion from NYS & Company. On a standalone basis, revenue grew about 23% to ₹6,445 lakhs and profit after tax rose roughly 25% to ₹186.77 lakhs (EPS ₹0.75). On a consolidated basis, revenue jumped nearly 29% to ₹17,187 lakhs and PAT grew about 30% to ₹325.55 lakhs (EPS ₹1.31), aided by two subsidiaries. The auditor flagged key audit matters around irregular TDS compliance, absence of an internal audit report, and reliance on management certifications for certain balances, but did not modify the opinion. The company raised ₹4.20 crore via a preferential issue in June 2024, fully utilised for working capital with no deviation. Operating cash flow on a standalone basis remained negative (₹-79.58 lakhs vs ₹-126.06 lakhs last year) despite higher reported profits.
Strong top-line and earnings growth at both standalone and consolidated levels, combined with a clean audit opinion, is a positive signal for shareholders. However, the persistent negative operating cash flow on a standalone basis and the auditor's flagged control and compliance weaknesses are points investors should watch closely.